Wednesday, August 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 18, 2026

Record Highs in the S&P 500 Show Selling on War Headlines Is Usually a Mistake

View original at nasdaq.com
Record Highs in the S&P 500 Show Selling on War Headlines Is Usually a Mistake Key Points The S&P 500 index reached record highs on April 16 despite the volatility of the Iran war…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Most recent wars have not had a significant long-term impact on the stock market

    60% confidence

  • S&P 500 profit margins were at new highs of 15% as of early April

    60% confidence

  • A close connection doesn't exist between recent wars and long-term stock market performance, whether involving smaller countries like Kosovo or Iraq, or major exporters like Russia and Ukraine

    60% confidence

  • Wall Street analysts expect 12% earnings growth from the S&P 500 for the current quarter

    60% confidence

Data points we hold from this source

S&P 500 · stock price7041.28 index_points
S&P 500 · ytd return2.9 percent
S&P 500 · return since march 30 low11 percent
S&P 500 · profit margin15 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Record Highs in the S&P 500 Show Selling on War Headlines Is Usually a Mistake — Source | Via News | ViaNews Market